June not off to a good start
I haven't participated in much of the talk about stocks in this forum but figured i'd start the chat out for June. Rough start to the month.
WASHINGTON — The Federal Reserve chairman, Ben S. Bernanke, signaled on Tuesday that further interest rate cuts were unlikely because of concerns about inflation.
High oil prices are a double-edged sword that can both put a damper on already weak growth and spread inflation, he said.
Mr. Bernanke, in remarks delivered via satellite to an international monetary conference in Barcelona, Spain, said that the Fed’s powerful doses of rate reductions, which started in September, along with the government’s $168 billion stimulus package, including rebates for people and tax breaks for businesses, should bring about “somewhat better economic conditions” in the second half of this year.
To help brace the economy, the Fed in late April dropped its key rate to 2 percent, a nearly four-year low, but hinted that could be the last reduction for a while. Mr. Bernanke drove that point home again on Tuesday.
“For now policy seems well positioned to promote moderate growth and price stability over time,” he said.
The Fed’s juggling act has become harder. It is trying to right a wobbly economy without aggravating inflation.
Many economists believe the Fed will hold rates steady at its next meeting in late June and probably through much, if not all, of this year. A few believe that inflation could flare up and force the Fed to begin increasing rates near the end of this year.
But Mr. Bernanke suggested that leaving rates at their current levels should be sufficient to accomplish the Fed’s twin goals of nurturing economic growth while preventing inflation from taking off.
Economic growth in the current quarter, he acknowledged, is “likely to be relatively weak.” Even as he reiterated the Fed’s hope for a pickup in growth in the second half of this year and into 2009, Mr. Bernanke said the economy continued to battle against negative forces — a housing slump, credit problems and fragile financial markets.
Until the slumping housing market and falling home prices show “clearer signs of stabilization,” there will continue to be threats to improved economic growth, he said. Moreover, recent increases in oil prices pose “additional downside risks to growth,” he said.
At the same time, if already lofty oil prices, now above $124 a barrel, continue to rise, that could worsen inflation, Mr. Bernanke warned.
The Fed’s aggressive rate-cutting campaign has contributed to a lower value for the dollar. That, in turn, has helped push up the prices for imported goods flowing into the United States and fueled a rise in consumer prices. Mr. Bernanke called that development “unwelcome.” He said the Fed was “attentive to the implications of changes in the value of the dollar for inflation and inflation expectations.”
During a question-and-answer session, Mr. Bernanke called the dollar’s impact on the rise in commodity prices “relatively modest” and said that global supply and demand were more important factors driving up energy prices and other prices. Still, the “weaker dollar does have inflationary impact,” and the Fed is attuned to that, he said.
WASHINGTON — The Federal Reserve chairman, Ben S. Bernanke, signaled on Tuesday that further interest rate cuts were unlikely because of concerns about inflation.
High oil prices are a double-edged sword that can both put a damper on already weak growth and spread inflation, he said.
Mr. Bernanke, in remarks delivered via satellite to an international monetary conference in Barcelona, Spain, said that the Fed’s powerful doses of rate reductions, which started in September, along with the government’s $168 billion stimulus package, including rebates for people and tax breaks for businesses, should bring about “somewhat better economic conditions” in the second half of this year.
To help brace the economy, the Fed in late April dropped its key rate to 2 percent, a nearly four-year low, but hinted that could be the last reduction for a while. Mr. Bernanke drove that point home again on Tuesday.
“For now policy seems well positioned to promote moderate growth and price stability over time,” he said.
The Fed’s juggling act has become harder. It is trying to right a wobbly economy without aggravating inflation.
Many economists believe the Fed will hold rates steady at its next meeting in late June and probably through much, if not all, of this year. A few believe that inflation could flare up and force the Fed to begin increasing rates near the end of this year.
But Mr. Bernanke suggested that leaving rates at their current levels should be sufficient to accomplish the Fed’s twin goals of nurturing economic growth while preventing inflation from taking off.
Economic growth in the current quarter, he acknowledged, is “likely to be relatively weak.” Even as he reiterated the Fed’s hope for a pickup in growth in the second half of this year and into 2009, Mr. Bernanke said the economy continued to battle against negative forces — a housing slump, credit problems and fragile financial markets.
Until the slumping housing market and falling home prices show “clearer signs of stabilization,” there will continue to be threats to improved economic growth, he said. Moreover, recent increases in oil prices pose “additional downside risks to growth,” he said.
At the same time, if already lofty oil prices, now above $124 a barrel, continue to rise, that could worsen inflation, Mr. Bernanke warned.
The Fed’s aggressive rate-cutting campaign has contributed to a lower value for the dollar. That, in turn, has helped push up the prices for imported goods flowing into the United States and fueled a rise in consumer prices. Mr. Bernanke called that development “unwelcome.” He said the Fed was “attentive to the implications of changes in the value of the dollar for inflation and inflation expectations.”
During a question-and-answer session, Mr. Bernanke called the dollar’s impact on the rise in commodity prices “relatively modest” and said that global supply and demand were more important factors driving up energy prices and other prices. Still, the “weaker dollar does have inflationary impact,” and the Fed is attuned to that, he said.
My Sept $35 HANS calls are almost in the money already! working out great so far.
I bought some AMZN calls today.
Does anyone know anything about VVUS? that is V V U S, not WUS
My Sept $35 HANS calls are almost in the money already! working out great so far.
I bought some AMZN calls today.
Does anyone know anything about VVUS? that is V V U S, not WUS
My Sept $35 HANS calls are almost in the money already! working out great so far.
I bought some AMZN calls today.
Does anyone know anything about VVUS? that is V V U S, not WUS
My Sept $35 HANS calls are almost in the money already! working out great so far.
I bought some AMZN calls today.
Does anyone know anything about VVUS? that is V V U S, not WUS
VIVUS, Inc (NASDAQ: VVUS) a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that the results from OB-202, a 28-week, placebo controlled, safety and efficacy phase 2 study to determine glycemic control in type 2 diabetics treated with Qnexa, will be delivered as a podium presentation during the American Diabetes Association (ADA) meeting in San Francisco, California, by Dr. Timothy Garvey, at 7:30 am PT Tuesday June 10, 2008.
Results from the study will include; glycemic control as measured by a the change of glycosylated hemoglobin (HbA1c) levels, changes in fasting glucose, percent of baseline body weight lost and changes in cardiovascular risk factors.
Following the podium presentation, VIVUS will host an investor event, where Dr. Garvey and members of VIVUS management will discuss the results of the OB-202 study.
The investor event will take place at the W Hotel, San Francisco, at 11:30 am PT. Investors and analysts are welcomed to attend this event and may register via RSVP to Ian Clements from the Trout Group at iclements@troutgroup.com or by calling 415-392-3385. A live audio webcast and 14-day archive of the presentation will be available at https://ir.vivus.com.
About the ADA Presentation
The presentation will be delivered, by Dr. Timothy Garvey, during the oral abstract session entitled: Clinical Diabetes: Emerging Trends. Details of this session and the presentation are as follows:
Date: Tuesday, June 10, 2008 Session Info: Oral Session: Clinical Diabetes: Emerging Trends (7:30am-9:30am) Presentation Time: 07:30am PT Room: Room 130, Moscone CenterVIVUS, Inc (NASDAQ: VVUS) a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that the results from OB-202, a 28-week, placebo controlled, safety and efficacy phase 2 study to determine glycemic control in type 2 diabetics treated with Qnexa, will be delivered as a podium presentation during the American Diabetes Association (ADA) meeting in San Francisco, California, by Dr. Timothy Garvey, at 7:30 am PT Tuesday June 10, 2008.
Results from the study will include; glycemic control as measured by a the change of glycosylated hemoglobin (HbA1c) levels, changes in fasting glucose, percent of baseline body weight lost and changes in cardiovascular risk factors.
Following the podium presentation, VIVUS will host an investor event, where Dr. Garvey and members of VIVUS management will discuss the results of the OB-202 study.
The investor event will take place at the W Hotel, San Francisco, at 11:30 am PT. Investors and analysts are welcomed to attend this event and may register via RSVP to Ian Clements from the Trout Group at iclements@troutgroup.com or by calling 415-392-3385. A live audio webcast and 14-day archive of the presentation will be available at https://ir.vivus.com.
About the ADA Presentation
The presentation will be delivered, by Dr. Timothy Garvey, during the oral abstract session entitled: Clinical Diabetes: Emerging Trends. Details of this session and the presentation are as follows:
Date: Tuesday, June 10, 2008 Session Info: Oral Session: Clinical Diabetes: Emerging Trends (7:30am-9:30am) Presentation Time: 07:30am PT Room: Room 130, Moscone CenterIf you choose to make use of any information on this website including online sports betting services from any websites that may be featured on this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.